FDA Inspection
Shandong Ruiying Pioneer Pharmaceutical Co., LtdShandong Ruiying Pioneer Pharmaceutical Co., Ltd – FDA Inspection, Mar 22, 2019
Record Details
This FDA Inspection record concerns Shandong Ruiying Pioneer Pharmaceutical Co., Ltd, with an inspection on March 22, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- March 22, 2019
- Product Type
- Drugs
View Company Profile
ID · 25050831-a9e8-4a77-aa7c-4521a632078f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1086433
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Shandong Ruiying Pioneer Pharmaceutical Co., Ltd
3| Date | Classification | Office | Project area |
|---|---|---|---|
| March 7, 2025 | Not classified | Office of Inspections and Investigations | |
| March 27, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 17, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Shandong Ruiying Pioneer Pharmaceutical Co., Ltd
- FDA Inspection 1264014 - 2025-03-07
- FDA Inspection 920919 - 2015-03-27
- FDA Inspection 707439 - 2010-09-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.